Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69601 - 69625 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	BCL2A1	597	upregulated	Silicon Dioxide analog results in increased expression of BCL2A1 mRNA	15q25.1	A24194 A24195
Silicon dioxide	Approved	BCL2A1	597	upregulated	Silicon Dioxide results in increased expression of BCL2A1 mRNA	15q25.1	A24200 A24197 A24196
Silicon dioxide	Approved	BCL2L10	10017	downregulated	Silicon Dioxide analog results in decreased expression of BCL2L10 mRNA	15q21.2	A24195
Silicon dioxide	Approved	BCL2L11	10018	downregulated	Silicon Dioxide analog results in decreased expression of BCL2L11 mRNA	2q13	A24195
Silicon dioxide	Approved	BCL2L11	10018	downregulated	Silicon Dioxide results in decreased expression of BCL2L11 mRNA	2q13	A24196
Silicon dioxide	Approved	BCL2L13	23786	downregulated	Silicon Dioxide results in decreased expression of BCL2L13 mRNA	22q11.21	A24196
Silicon dioxide	Approved	BCL3	602	downregulated	Silicon Dioxide analog results in decreased expression of BCL3 mRNA	19q13.32	A24195
Silicon dioxide	Approved	BCL6	604	downregulated	Silicon Dioxide analog results in decreased expression of BCL6 mRNA	3q27.3	A24195
Silicon dioxide	Approved	BCO1	53630	downregulated	Silicon Dioxide analog results in decreased expression of BCO1 mRNA	16q23.2	A24195
Silicon dioxide	Approved	BCS1L	617	upregulated	Silicon Dioxide analog results in increased expression of BCS1L mRNA	2q35	A24195
Silicon dioxide	Approved	BDH2	56898	downregulated	Silicon Dioxide analog results in decreased expression of BDH2 mRNA	4q24	A24195
Silicon dioxide	Approved	BDKRB1	623	downregulated	Silicon Dioxide analog results in decreased expression of BDKRB1 mRNA	14q32.2	A24195
Silicon dioxide	Approved	BDKRB1	623	upregulated	Silicon Dioxide results in increased expression of BDKRB1 mRNA	14q32.2	A24196
Silicon dioxide	Approved	BDKRB2	624	downregulated	Silicon Dioxide analog results in decreased expression of BDKRB2 mRNA	14q32.2	A24195
Silicon dioxide	Approved	BEAN1	146227	upregulated	Silicon Dioxide analog results in increased expression of BEAN1 mRNA	16q21	A24194
Silicon dioxide	Approved	BEND3	57673	upregulated	Silicon Dioxide analog results in increased expression of BEND3 mRNA	6q21	A24195
Silicon dioxide	Approved	BEND5	79656	downregulated	Silicon Dioxide analog results in decreased expression of BEND5 mRNA	1p33	A24195
Silicon dioxide	Approved	BEND5	79656	upregulated	Silicon Dioxide analog results in increased expression of BEND5 mRNA	1p33	A24194
Silicon dioxide	Approved	BEND6	221336	downregulated	Silicon Dioxide analog results in decreased expression of BEND6 mRNA	6p12.1	A24195
Silicon dioxide	Approved	BEST1	7439	downregulated	Silicon Dioxide analog results in decreased expression of BEST1 mRNA	11q12.3	A24195
Silicon dioxide	Approved	BEST3	144453	upregulated	Silicon Dioxide analog results in increased expression of BEST3 mRNA	12q15	A24195
Silicon dioxide	Approved	BEX4	56271	upregulated	Silicon Dioxide analog results in increased expression of BEX4 mRNA	Xq22.1	A24195
Silicon dioxide	Approved	BHLHE40	8553	upregulated	Silicon Dioxide results in increased expression of BHLHE40 mRNA	3p26.1	A24196
Silicon dioxide	Approved	BHLHE41	79365	upregulated	Silicon Dioxide analog results in increased expression of BHLHE41 mRNA	12p12.1	A24195
Silicon dioxide	Approved	BHLHE41	79365	upregulated	Silicon Dioxide results in increased expression of BHLHE41 mRNA	12p12.1	A24197 A24196

Displaying entries 69601 - 69625 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability